{
    "2021-05-17": [
        [
            {
                "time": "2018-03-05",
                "original_text": "Supreme Court Rebuffs Novartis Appeal Over Amgen's Arthritis Drug Enbrel: Report",
                "features": {
                    "keywords": [
                        "Supreme Court",
                        "Novartis",
                        "Amgen",
                        "Arthritis",
                        "Drug",
                        "Enbrel"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2018-03-06",
                "original_text": "Novartis' Entresto Misses Primary Endpoint In Study After Heart Attacks",
                "features": {
                    "keywords": [
                        "Novartis",
                        "Entresto",
                        "Primary Endpoint",
                        "Study",
                        "Heart Attacks"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2018-03-07",
                "original_text": "US Supreme Court denies Sandoz petition to review biosimilar ErelziÂ® (etanercept-szzs) case",
                "features": {
                    "keywords": [
                        "US Supreme Court",
                        "Sandoz",
                        "petition",
                        "biosimilar",
                        "Erelzi",
                        "case"
                    ],
                    "sentiment_score": -0.5,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2018-03-08",
                "original_text": "UPDATE 2-U.S. Supreme Court snubs Novartis appeal over arthritis drug Enbrel",
                "features": {
                    "keywords": [
                        "U.S. Supreme Court",
                        "Novartis",
                        "arthritis",
                        "drug",
                        "Enbrel"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2018-03-09",
                "original_text": "U.S. Supreme Court snubs Novartis appeal over arthritis drug Enbrel",
                "features": {
                    "keywords": [
                        "U.S. Supreme Court",
                        "Novartis",
                        "arthritis",
                        "drug",
                        "Enbrel"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            }
        ]
    ]
}